Tirzepatide Injection Site Reactions: Vials, Syringes & What's Normal
Injection site reactions on tirzepatide are uncommon, and they usually show up as a little redness, itching or bruising where the needle went in, whether you use a pen or draw tirzepatide from a vial. In weight-loss trials of FDA-approved tirzepatide, 6–8% of people had one, compared with 2% on placebo, so more than 9 in 10 people never did (Zepbound prescribing information). Glapp, the GLP-1 tracker, lets you log any reaction on shot day right next to your tirzepatide dose, so you can see shot by shot whether they're fading.
Key numbers
| Number | What it means |
|---|---|
| 6–8% | of people on tirzepatide had an injection site reaction in weight-loss trials, vs 2% on placebo |
| 4,871 | users currently tracking tirzepatide-related injection site reactions in Glapp |
Tirzepatide injection site reactions: what the clinical evidence shows
The best evidence on tirzepatide comes from the FDA-approved versions, Zepbound and Mounjaro, which contain the same molecule and come in prefilled pens or vials. In the pooled weight-loss trials behind Zepbound's prescribing information:
| Side effect | Placebo | 5 mg | 10 mg | 15 mg |
|---|---|---|---|---|
| Injection site reactions* | 2% | 6% | 8% | 8% |
| Hypersensitivity (allergic) reactions | 3% | 5% | 5% | 5% |
*Includes bruising, redness, itching, pain, rash and general reaction at the injection site. Source: Zepbound prescribing information, Table 1 and section 6.1.
Reactions were reported in 11.3% of people who developed antibodies to tirzepatide, compared with 1% of those who didn't. Severe allergic reactions were reported in 0.1% of people on tirzepatide.
Why does tirzepatide cause injection site reactions?
The trial data point to the immune response as a factor: people whose bodies made antibodies to tirzepatide were about ten times more likely to have a reaction. Most reactions are local and mild, such as bruising, redness or itching.
Injecting from a vial: rotation, clean technique and telling a reaction from an allergy
- Rotate where you inject. Use a different spot each week: your stomach (at least 2 inches from your belly button), your thigh, or the back of your upper arm if someone else injects. Using the same spot again and again makes reactions more likely.
- Keep it clean. Wipe the vial's rubber stopper and your skin with alcohol and let them dry, use a new sterile syringe every time, and never share syringes or vials. Don't use a vial that looks cloudy, discolored or has particles in it unless your pharmacy says that's expected.
- What a normal reaction looks like. Redness, itching, mild pain, a small bruise or a little bump right where the needle went in. It stays at the site and fades on its own.
- Signs of infection. Redness that spreads, warmth, swelling that keeps growing, pus or a fever. Call your prescriber promptly.
- What an allergic reaction looks like. Hives or a rash spreading beyond the site, swelling of your face, lips, tongue or throat, trouble breathing or feeling faint. That's an emergency: get help straight away.
Track your tirzepatide injection site reactions with a GLP-1 tracker app
A reaction after one shot can be worrying; four shots side by side tell you what's really going on. That's what a GLP-1 tracker is for: log your injection site on shot day and the day after, and you're in control. You'll know how often reactions happen, how strong they are, how long they last and whether they're fading.
Why Glapp? It's a top-rated GLP-1 tracker used by 100,000+ people, rated 4.8/5 on Trustpilot and the App Store, and 4.6/5 on Google Play. Glapp grew out of Reddit GLP-1 support groups and is built by people who take GLP-1 medications themselves, which is why it handles the everyday side of compounded tirzepatide that brand-name pen trackers skip:
- Built-in dosage calculator. Glapp shows the units for the dose and concentration you enter. Confirm with your pharmacist.
- Vial and supply tracking. Every dose you log comes off your active vial, so you always know what's left, down to the unit.
It's grounded in published clinical trial data and peer-reviewed research, core tracking is free, and you get custom titration curves plus syncing across iPhone, Android and web. Here's how to use it over your next four shots.
Glapp does not provide medical advice or treat side effects. It shows your daily check-ins against your estimated medication levels so you have structured data to share with your prescriber.
Shot 1: Start tracking your injection site reactions
Use Glapp's daily check-in to record any injection site reaction on shot day and rate how severe it feels. Check in again the next day so you capture how long it lasts. Log your dose in mg, worked out from your units and your vial's concentration.
These entries help you see whether reactions are getting better, getting worse or staying the same from one shot to the next. You'll have a clear record without having to remember each one.
Shot 2: See how your reactions change over time
Open the side-effects chart in the Progress tab and choose the period you want to review. Your ratings appear on a timeline next to your shots, making it easier to see whether a bad reaction was a one-off or part of a pattern.
Shot 3: Look for patterns in your weekly report
Glapp's weekly progress report brings your logged data together, with dedicated sections showing your side effects and how they change.
Do reactions show up with every shot or only some? Did they start with a new vial? Do they last one day or several? Reviewing several shots side by side can help you spot patterns that are easy to miss, and give you specific questions to discuss with your doctor.
Shot 4: Bring a clear record to your doctor
After four shots, review the bigger picture: are reactions becoming less frequent, staying the same or getting worse?
Create a doctor's report in Glapp and choose the information to include. Your doctor can review your symptom history alongside your doses and progress, giving you a more focused conversation about your treatment and your injection technique.
Start tracking your tirzepatide injections in Glapp
Reactions and dose steps on compounded tirzepatide: units, mg and why measuring matters
Tirzepatide usually starts at 2.5 mg once a week and steps up by 2.5 mg at least four weeks apart, to a maintenance dose between 5 and 15 mg. In the trials, reactions were reported in 6% at 5 mg and 8% at 10 and 15 mg.
Tirzepatide from a vial is drawn up with a U-100 insulin syringe, where 1 unit = 0.01 mL. How many mg that holds depends on your vial's concentration:
mg = units × concentration (mg/mL) ÷ 100
| Dose | Units at 10 mg/mL | Units at 20 mg/mL |
|---|---|---|
| 2.5 mg | 25 | 12.5 |
| 5 mg | 50 | 25 |
| 7.5 mg | 75 | 37.5 |
| 10 mg | 100 | 50 |
| 12.5 mg | 125 | 62.5 |
| 15 mg | 150 | 75 |
Example concentrations only. Concentrations vary between pharmacies, so always use the concentration on your vial and your prescriber's or pharmacist's instructions. Over 100 units is more than a U-100 syringe holds. Ask your pharmacist.
At a lower concentration, the same dose means more liquid per injection. If reactions seem tied to bigger volumes or a new vial, note it in Glapp and ask your pharmacist.
What to bring to your prescriber
A shot-by-shot log shows your prescriber the pattern at a glance:
| Shot date | Dose (mg / units) | Site | Reaction on shot day | Still there day 2? | Type |
|---|---|---|---|---|---|
| Example Sun 1 Nov | 10 mg / 50 units | Stomach, left | Med | Yes | Redness, itching |
| Example Sun 8 Nov | 10 mg / 50 units | Thigh, right | Low | No | Redness |
| Example Sun 15 Nov | 10 mg / 50 units | Stomach, right | Low | No | Bruising |
| Example Sun 22 Nov | 10 mg / 50 units | Thigh, left | None logged | No | – |
Questions you could ask. They're conversation starters, not recommendations; your prescriber decides what, if anything, to change.
- "I get redness and itching after most shots. Is that the kind of reaction you'd expect?"
- "Could you or my pharmacist check how I draw up and inject from the vial?"
- "How do I tell a normal reaction from an infection or an allergy?"
Frequently asked questions
Are injection site reactions more common with compounded tirzepatide?
No trials compare them. Even when it's the same molecule, injecting from a vial adds steps, and pharmacy-made versions aren't reviewed by the FDA for safety, effectiveness or quality before they're marketed. Clean technique and site rotation matter even more from a vial.
How long do tirzepatide injection site reactions last?
Most are mild and short-lived, fading on their own within a few days, and rotating where you inject each week helps. If a reaction keeps growing, spreads, feels hot or lasts more than a week, show it to your prescriber.
Is a lump at the tirzepatide injection site normal?
A small bump right where the needle went in is a common local reaction and usually fades. A lump that grows, feels hot, is very painful or comes with fever needs checking for infection.
How do I track tirzepatide injection site reactions?
Log the reaction in Glapp's daily check-in on shot day and the day after, rating it low, medium or high, with your dose in mg. Progress and your weekly reports show whether reactions are fading shot to shot.
About the data
Ratings are self-reported. This page is for information only and is not medical advice; talk to your prescriber about any side effect.
About the author
We're GLP-1 patients and health tech professionals, building Glapp in collaboration with doctors. About us
Sources
- Eli Lilly. Zepbound (tirzepatide) prescribing information: Table 1, section 6.1 (injection site reactions, immunogenicity), warnings (hypersensitivity reactions), instructions for use.
- U.S. Food and Drug Administration. FDA's concerns with unapproved GLP-1 drugs used for weight loss.